Sign Up Today and Learn More About Thrive Bioscience Stock
Invest in or calculate the value of your shares in Thrive Bioscience or other pre-IPO companies through EquityZen's platform.
Thrive Bioscience Stock
Thrive sells instruments and software that automate with extensive imaging, analytics, and AI manual and stem cell culture.
About Thrive Bioscience Stock
Founded
2014
Headquarters
Beverly, MA, US
Industries
Artificial Intelligence, Software, Data and Analytics
Thrive Bioscience Press Mentions
Stay in the know about the latest news on Thrive Bioscience
Live Cell Imaging Market Outlook 2025-2030 | Leveraging AI and Big Data with Oblique Illumination Technology
globenewswire • May 08, 2025
Live Cell Imaging Market Focused Insights Report 2025-2030, Profiling Agilent Technologies, BD, Danaher, PerkinElmer, Merck KgaA, Thermo Fisher Scientific and Zeiss - ResearchAndMarkets.com
businesswire • May 06, 2025
Automated cell culture incubator
patents • May 04, 2025
Networked incubator operation
patents • May 04, 2025
Method and system for cell operations using the internet of things
patents • Apr 02, 2025
Thrive Bioscience Management
Leadership team at Thrive Bioscience
President, CEO & Board Member
Thomas Forest Farb
Cofounder & CSO
Alan P. Blanchard
Join now and verify your accreditation status to gain access to:
- Thrive Bioscience Current Valuation
- Thrive Bioscience Stock Price
- Thrive Bioscience Management
- Available deals in Thrive Bioscience and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Thrive Bioscience Cap Table and Funding History by Share Class and Liquidity Preferences
- Thrive Bioscience Revenue and Financials
- Thrive Bioscience Highlights
- Thrive Bioscience Business Model
- Thrive Bioscience Risk Factors
- Thrive Bioscience Research Report from SACRA Research
Trading Thrive Bioscience Stock
How to invest in Thrive Bioscience stock?
Accredited investors can buy pre-IPO stock in companies like Thrive Bioscience through EquityZen funds. These investments are made available by existing Thrive Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Thrive Bioscience stock?
Shareholders can sell their Thrive Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."